October 24, 2018

TB Alliance Joins Innovative Medicines Initiative to Accelerate Development of New TB Cures

European Public-Private Partnership Enables Research to Combat Health Threats, including Drug-Resistant Tuberculosis
September 26, 2018

Statement on UN High-Level Meeting on TB

The world is listening and expecting true commitment and change
September 19, 2018

TB Alliance and Liverpool School of Tropical Medicine Collaborate to Develop New TB Therapies

New partnership supported by Medical Research Council to research drug regimens to fight drug-resistant tuberculosis
September 18, 2018

Once Again, New TB Numbers Underscore the Need for New Treatments

Statement from TB Alliance on WHO Global TB Report 2018
August 28, 2018

SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia

New pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multidrug-resistant tuberculosis
August 17, 2018

TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment

Forthcoming Recommendations Point to Treatment Changes for Drug-Resistant TB
July 13, 2018

TB Alliance Names Angela Vanderploeg as Chief Financial Officer

Vanderploeg Brings Comprehensive Financial Management Experience to Help Guide Pursuit of Life-Saving New Tuberculosis Therapies
July 6, 2018

In Memory of Professor Denis Mitchison

Statement from TB Alliance
June 5, 2018

Statement on Civil Society Hearing on the UN High Level Meeting on Tuberculosis

PDPs urge commitment to tripling the overall annual investments in TB R&D
June 4, 2018

TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access

Juneja Brings Industry Expertise to Initiatives that Accelerate Access to New TB Drug Regimens